<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="733125" id="root" date="1997-07-16" xml:lang="en">
<title>USA: Blood pressure drugs cut heart failure risk - study.</title>
<headline>Blood pressure drugs cut heart failure risk - study.</headline>
<dateline>CHICAGO 1997-07-15</dateline>
<text>
<p>Diuretics commonly used to treat high blood pressure significantly reduced the risk of heart failure among older patients, a study said on Tuesday.</p>
<p>Researchers tracked 4,376 people age 60 or older who participated in the Systolic Hypertension in the Elderly Program (SHEP). Participants were randomly given the diuretic chlorthalidone, or a placebo.</p>
<p>Fatal or non-fatal heart failure occurred in 55, or 2.3 percent, of the 2,365 patients given the diuretic, compared to 105, or 4.4 percent, of the 2,371 people taking the placebo, the researchers found.</p>
<p>&quot;This analysis from SHEP indicates a marked effect of the diuretic-based stepped-care therapy in preventing development of heart failure in older patients with isolated systolic hypertension,&quot; wrote study author John Kostis of the University of Medicine and Dentistry of New Brunswick, New Jersey.</p>
<p>The study appeared in the Journal of the American Medical Association.</p>
<p>The actual benefit may be greater than the research showed because a large proportion of the patients receiving the placebo crossed over to more active therapy.</p>
<p>Diuretics, or anti-hypertensive drugs, may reduce the risk of heart failure by lowering systolic blood pressure, reducing the thickness of the heart muscle wall and improving the heart's ability to relax and cut its workload, the researchers said. Systolic blood pressure is considered high when it rises above 160 while the lower, or diastolic number, is normal.</p>
<p>Heart failure afflicts more than 2 million people annually in the United States and results in roughly one million hospitalizations. For those 60 and older, it is the most common reason for hospital admission.</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-16"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="GCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-16"/>
  </code>
  <code code="GHEA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-16"/>
  </code>
  <code code="GSCI">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-16"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-07-15"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-07-16"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="CHICAGO"/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
